Literature DB >> 229699

CSF levels of cyclic nucleotides in primary intracranial neoplasms: a preliminary report.

M Gerosa, P Cisotto, A Carteri.   

Abstract

Recent evidence indicates that cyclic nucleotides are of importance for general and neurosurgical oncology, especially with respect to the contact-inhibition mechanisms and tumour cell growth. This preliminary report deals with the CSF levels of c-AMP and c-GMP in primary neoplasms in children and to problems related to the blood-brain barrier. Some cases of medulloblastoma were studied as well as a few cases of brain stem glioma and cystic astrocytoma. The importance of some rather unusual findings seems undebatable, i.e., the marked increase in c-GMP values usually observed in medulloblastoma and the decrease of c-AMP, that is fairly common in all malignant neoplasms. The main changes in the c-AMP/c-GMP ratio are also discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229699     DOI: 10.1007/bf01813550

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

Review 1.  Regulation of cyclic AMP content in normal and malignant brain cells.

Authors:  J P Perkins; M M Moore; A Kalisker; Y F Su
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

2.  Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  Arch Neurol       Date:  1973-09

3.  Urinary excretion and cerebrospinal fluid concentration of cyclic adenosine-3',5'-monophosphate in various neurological diseases.

Authors:  E R Heikkinen; V V Myllylä; H Vapaatalo; E Hokkanen
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

4.  Adenosine 3',5'-cyclic monophosphate and contact inhibition.

Authors:  M L Heidrick; W L Ryan
Journal:  Cancer Res       Date:  1971-09       Impact factor: 12.701

Review 5.  Cyclic GMP.

Authors:  N D Goldberg; R F O'Dea; M K Haddox
Journal:  Adv Cyclic Nucleotide Res       Date:  1973

6.  Neurotransmitters.

Authors:  J Axelrod
Journal:  Sci Am       Date:  1974-06       Impact factor: 2.142

7.  Cyclic AMP and adenyl cyclase in brain tumors.

Authors:  M A Furman; K Shulman
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

8.  Guanosine 3'-5'-monophosphate in the CSF of neurological patients.

Authors:  M Trabucchi; C Cerri; P F Spano; K Kumakura
Journal:  Arch Neurol       Date:  1977-01

9.  Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3':5'-cyclic monophosphate.

Authors:  J R Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.